Buck et al. performed FAIRE on matched pairs of tumor/healthy samples and identified decreased chromatin accessibility at genes previously associated with ccRCC, such as PBRM1, SETD2 and MLL2 (60). This evidence concerns the gene PBRM1 and nonpapillary renal cell carcinoma.